Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

The Unequal Burden of Cancer: An Assessment of NIH Research and Programs for Ethnic Minorities and the Medically Underserved.

Institute of Medicine (US) Committee on Cancer Research Among Minorities and the Medically Underserved; Haynes MA, Smedley BD, editors.

Washington (DC): National Academies Press (US); 1999.

2.

Racial differences in trust and regular source of patient care and the implications for prostate cancer screening use.

Carpenter WR, Godley PA, Clark JA, Talcott JA, Finnegan T, Mishel M, Bensen J, Rayford W, Su LJ, Fontham ET, Mohler JL.

Cancer. 2009 Nov 1;115(21):5048-59. doi: 10.1002/cncr.24539.

3.

Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group.

Albain KS, Unger JM, Crowley JJ, Coltman CA Jr, Hershman DL.

J Natl Cancer Inst. 2009 Jul 15;101(14):984-92. doi: 10.1093/jnci/djp175. Epub 2009 Jul 7.

4.

Screening and prostate-cancer mortality in a randomized European study.

Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Berenguer A, Määttänen L, Bangma CH, Aus G, Villers A, Rebillard X, van der Kwast T, Blijenberg BG, Moss SM, de Koning HJ, Auvinen A; ERSPC Investigators.

N Engl J Med. 2009 Mar 26;360(13):1320-8. doi: 10.1056/NEJMoa0810084. Epub 2009 Mar 18.

5.

Mortality results from a randomized prostate-cancer screening trial.

Andriole GL, Crawford ED, Grubb RL 3rd, Buys SS, Chia D, Church TR, Fouad MN, Gelmann EP, Kvale PA, Reding DJ, Weissfeld JL, Yokochi LA, O'Brien B, Clapp JD, Rathmell JM, Riley TL, Hayes RB, Kramer BS, Izmirlian G, Miller AB, Pinsky PF, Prorok PC, Gohagan JK, Berg CD; PLCO Project Team.

N Engl J Med. 2009 Mar 26;360(13):1310-9. doi: 10.1056/NEJMoa0810696. Epub 2009 Mar 18. Erratum in: N Engl J Med. 2009 Apr 23;360(17):1797.

6.

Screening for prostate cancer--the controversy that refuses to die.

Barry MJ.

N Engl J Med. 2009 Mar 26;360(13):1351-4. doi: 10.1056/NEJMe0901166. Epub 2009 Mar 18. No abstract available.

7.

A matter of race: early-versus late-stage cancer diagnosis.

Virnig BA, Baxter NN, Habermann EB, Feldman RD, Bradley CJ.

Health Aff (Millwood). 2009 Jan-Feb;28(1):160-8. doi: 10.1377/hlthaff.28.1.160.

8.

Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: a case-control study.

Ulmert D, Cronin AM, Björk T, O'Brien MF, Scardino PT, Eastham JA, Becker C, Berglund G, Vickers AJ, Lilja H.

BMC Med. 2008 Feb 15;6:6. doi: 10.1186/1741-7015-6-6.

9.
10.

Hidden barriers between knowledge and behavior: the North Carolina prostate cancer screening and treatment experience.

Talcott JA, Spain P, Clark JA, Carpenter WR, Do YK, Hamilton RJ, Galanko JA, Jackman A, Godley PA.

Cancer. 2007 Apr 15;109(8):1599-606.

11.

Total, free, and percent free prostate-specific antigen levels among U.S. men, 2001-04.

Lacher DA, Thompson TD, Hughes JP, Saraiya M.

Adv Data. 2006 Dec 4;(379):1-12.

PMID:
17348177
12.

Adenocarcinoma of the prostate in Iceland: a population-based study of stage, Gleason grade, treatment and long-term survival in males diagnosed between 1983 and 1987.

Jonsson E, Sigbjarnarson HP, Tomasson J, Benediktsdottir KR, Tryggvadottir L, Hrafnkelsson J, Olafsdottir EJ, Tulinius H, Jonasson JG.

Scand J Urol Nephrol. 2006;40(4):265-71.

PMID:
16916765
13.

Prostate-specific antigen-based serial screening may decrease prostate cancer-specific mortality.

Efstathiou JA, Chen MH, Catalona WJ, McLeod DG, Carroll PR, Moul JW, Roehl KA, D'Amico AV.

Urology. 2006 Aug;68(2):342-7.

PMID:
16904449
14.
15.

Reduction of prostate cancer mortality in Tyrol, Austria, after introduction of prostate-specific antigen testing.

Oberaigner W, Horninger W, Klocker H, Schönitzer D, Stühlinger W, Bartsch G.

Am J Epidemiol. 2006 Aug 15;164(4):376-84. Epub 2006 Jul 7.

PMID:
16829552
16.

Disparities and survival among breast cancer patients.

Field TS, Buist DS, Doubeni C, Enger S, Fouayzi H, Hart G, Korner EJ, Lamerato L, Bachman DJ, Ellis J, Herrinton L, Hornbrook MC, Krajenta R, Liu L, Yao J.

J Natl Cancer Inst Monogr. 2005;(35):88-95.

PMID:
16287892
17.
18.

Racial differences in screening for prostate cancer in the elderly.

Gilligan T, Wang PS, Levin R, Kantoff PW, Avorn J.

Arch Intern Med. 2004 Sep 27;164(17):1858-64.

PMID:
15451760
19.
20.

Prostate cancer screening and mortality: a case-control study (United States).

Weinmann S, Richert-Boe K, Glass AG, Weiss NS.

Cancer Causes Control. 2004 Mar;15(2):133-8.

PMID:
15017125

Supplemental Content

Support Center